This 137% growth for IDXX stock since late 2018 can primarily be attributed to 1 the company’s P/S ratio rising 53% to 11.1x trailing revenues, from 7.3x in 2018, 2.

Idexx Laboratories (IDXX) came out with quarterly earnings of $2.96 per share, beating the Zacks Consensus Estimate of $2.92 per share. This compares to earnings of $2.81 per share a year ago ...

Animal diagnostics maker IDEXX Laboratories on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it benefited from customer retention and ...

IDEXX will offer a new canine lymphoma test in the U.S. and Canada in late March. Shares of IDEXX Laboratories surged 10% to lead S&P 500 gainers Monday after the provider of veterinary ...

WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the expansion of its Fecal Dx ® antigen testing ...

IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs nearly 11,000 people and offers solutions and products to customers in more than 175 countries.